Diluent

Prospera Energy Inc. Announces Development Update

Retrieved on: 
Thursday, November 9, 2023
Weather, FRA, ESG, Barrel, PEI, OTC, Oportunidades, Acquisition, Diluent, Solarmer Energy, Inc., API, Natural gas, Oil, Western Canada

CALGARY, Alberta, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (“Prospera” or the “Company”)

Key Points: 
  • CALGARY, Alberta, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (“Prospera” or the “Company”)
    Prospera has resumed the phase two development of the horizontal infill drilling program.
  • Prospera will continue the Phase 2 development program to increase production, aiming to achieve year-end targets and enhance Prospera’s share value.
  • Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) is a publicly traded energy company based in Western Canada, specializing in the exploration, development, and production of crude oil and natural gas.
  • Prospera Energy Inc. has announced a mid-August spud of PEI’s phase 2 restructured development program intended to increase production.

Prospera Energy Announces Q3 2023 Financials with First Closing of Debt Financing

Retrieved on: 
Wednesday, November 1, 2023
TSX Venture Exchange, FRA, ESG, Barrel, PEI, OTC, Legislation, Oportunidades, Acquisition, Diluent, Prospectus, API, Natural gas, Security (finance), Oil, Principle, Corporation, Western Canada

The company remains focused on minimal dilution financing options moving forward and if fully subscribed, this debt financing would represent less than 1% equity dilution.

Key Points: 
  • The company remains focused on minimal dilution financing options moving forward and if fully subscribed, this debt financing would represent less than 1% equity dilution.
  • A finder's fee in cash and/or warrants may be paid to eligible finders in relation to this financing.
  • Under this revised agreement, the Corporation will convert the debt into common share units of the Corporation (the "Common Share Units").
  • Prospera Energy Inc. has announced a mid-August spud of PEI’s phase 2 restructured development program intended to increase production.

PDA Announces 2023 Drug Delivery Innovation Award Winners at Universe of Pre-Filled Syringes Conference

Retrieved on: 
Tuesday, October 17, 2023
Universe, Chicago Innovation Awards, Partnership, ANSI, Stevanato Group, Parenteral Drug Association, PDA, Automation, Caregiver, WMG, University of Warwick, Digital platform, Global Smoke-Free Partnership Award, Organization, Limited partnership, Bayer, Ecosystem, Education, Merck, Science, PFS, Syringe, Patient, Diluent, Pharmaceutical industry, EU

BETHESDA, Md., Oct. 17, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2023 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Gothenburg, Sweden. Awardees were recognized for their technical innovations in advancing the field of bio/pharmaceutical manufacturing.

Key Points: 
  • BETHESDA, Md., Oct. 17, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2023 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Gothenburg, Sweden.
  • The companies recognized for the 2023 PDA Drug Delivery Innovation Awards are well-deserving of this honor and I congratulate them for their achievements and tireless effort to move the industry forward.
  • PDA recognizes the award winners each year at its annual Universe of Pre-Filled Syringes and Injection Devices conference, which is held in the U.S. in even years and the EU in odd years.
  • The PDA Drug Delivery Innovation Awards were created in 2019 to recognize technical innovations advancing the field of bio/pharmaceutical manufacturing.

Prospera Energy Inc. Commences Modular Horizontal Infill Well Program to Capture 400 million barrels of Remaining Oil

Retrieved on: 
Wednesday, August 16, 2023
Solarmer Energy, Inc., API, OTC, Diluent, ESG, Oportunidades, Weather-related cancellation, PEI, FRA, Oil

Prospera is pleased to announce the spudding of the first horizontal well of the ten well modular multi-pad infill drill program in the latter part of this week, subject to any weather-related or uncontrollable delays.

Key Points: 
  • Prospera is pleased to announce the spudding of the first horizontal well of the ten well modular multi-pad infill drill program in the latter part of this week, subject to any weather-related or uncontrollable delays.
  • This modular development is intended to accelerate production and recovery to capture the significant remaining heavy oil reserves (400 million bbls).
  • The medium-light oil spud will follow the heavy oil horizontal well transformation from vertical wells in the latter part of this month.
  • Overall, this phase 2 development plan will allow Prospera Energy to become a low-cost producer with a significant increase in production.

$11.5 Billion Pharmaceutical Excipients (Organic, Inorganic) Markets - Global Forecast to 2027: Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 19, 2022
Chemicals, Plastics, Health, Manufacturing, Other Manufacturing, Vitamins, Supplements, Pharmaceutical, Growth, Excipient, Tablet, Taste, CAGR, Patient, Income, Organic, Carbohydrate, Route of administration, Diluent, Filler (animal food), List, Key, Compound, USD, Fine chemical, Capsule, Lubricant

The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.

Key Points: 
  • The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.
  • The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients.
  • Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth.
  • Growing Pharmaceuticals Industry, Coupled with Advancements in Functional Excipients, are Key Factors Driving Market Growth

Global Prefilled Syringes Market to 2028 - Collaborations and Investments to Open an Array of Opportunities for the Market to Flourish - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022
Pharmaceutical, Health, Medical Devices, Geography, Completeness, Vaccine, Needle, CAGR, Heparin, Syringe, Safety, Glass, Machine taper, Hyaluronic acid, Diluent, Pet, Borosilicate glass

The prefilled syringes global market based on material is segmented into glass based prefilled syringes and polymer based prefilled syringes.

Key Points: 
  • The prefilled syringes global market based on material is segmented into glass based prefilled syringes and polymer based prefilled syringes.
  • The prefilled syringes global market based on design is grouped into single chamber prefilled syringes and dual chamber prefilled syringes.
  • The prefilled syringes global market based on closure system is classified into staked needle prefilled syringes, luer lock prefilled syringes and non-luer lock prefilled syringes.
  • The prefilled syringes global market based on application is categorized into heparin prefilled syringes, vaccines prefilled syringes, therapeutic drugs prefilled syringes, diluents prefilled syringes, surgical application prefilled syringes, hyaluronic acid prefilled syringes and other prefilled syringes applications (other anticoagulant prefilled syringes, saline flush prefilled syringes and contrast imaging agents prefilled syringes).

Aduro Clean Technologies to Present at Upcoming Conferences

Retrieved on: 
Thursday, June 2, 2022
HCT, Chemistry, R, Government, Innovation, API, Viscosity, Industry, Diluent, Canada, Water, Polyethylene, Climate change, Plastic, Carbon, Oil

HCT was developed by Aduro and it is a novel and versatile chemical platform for converting lower-value, higher-molecular-weight materials into higher-value feedstocks or products.

Key Points: 
  • HCT was developed by Aduro and it is a novel and versatile chemical platform for converting lower-value, higher-molecular-weight materials into higher-value feedstocks or products.
  • Unlocking the value of carbon embedded in plastics and bringing them into circularity is a key issue Aduro aims to address.
  • Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals.
  • With funding and support from Bioindustrial Innovation Canada , the company has developed a pre-pilot reactor system to upgrade heavy petroleum into lighter oil.

Pharmaceutical Excipients Global Market Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 30, 2022
Health, Pharmaceutical, Risk, The Pharmaceutical Journal, API, Medicine, Diluent, SE, United States v. Archer Daniels Midland Co., Patient, Associated British Foods, BASF, Excipient, Roquette Frères, Fertin Pharma, Dow Chemical Company, Marketing, Philip Morris International, Research, Glidant, Drug, Compliance, Safety, Function, Lubricant, Sale, PMI, BASF SE, India Brand Equity Foundation, Organic, Ethanol, Acquisition, Growth, Compound, Generic drug, Pharmaceutical industry

The "Pharmaceutical Excipients Global Market Report 2022: By Functionality, By Type, By Product" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Excipients Global Market Report 2022: By Functionality, By Type, By Product" report has been added to ResearchAndMarkets.com's offering.
  • The pharmaceutical excipients market consists of sales of pharmaceutical excipients and related services.
  • The market consists of revenue generated by the company's manufacturing the pharmaceutical excipients by the sales of these excipients
    The main types of products in pharmaceutical excipients are inorganic chemicals and organic chemicals.
  • The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market.

Kanabo Launches eCommerce Platform to Help Improve Wellbeing of Millions of People

Retrieved on: 
Wednesday, March 23, 2022
Biotechnology, Pharmaceutical, Alternative Medicine, Health, Tobacco, Medical Devices, Online Retail, Retail, VG, Terpene, Cannabinoid, PEG, MCT, London, Capsule, CEO, Health, Diluent, EU, Quality of life, London Stock Exchange, CBG, Reload, PG, Maintenance (technical), Physician, Inhalation, Cannabis, IPO, E-commerce, Patient, Medicinal plants, Kanabō, CBD

Kanabo, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers.

Key Points: 
  • Kanabo, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers.
  • Avihu Tamir, founder and CEO of Kanabo, said: Our VapePod is a game-changer for CBD consumers who aim to improve their health and quality of life.
  • No other CBD delivery system currently on the market offers the same precise, metered dosing solution that the VapePod consistently provides.
  • We use the highest quality hemp-derived natural ingredients which makes the VapePod the most effective CBD delivery system in the world.

Bio-Alcohol Market to Reach Valuation of US$ 419.75 bn by 2031, TMR Report

Retrieved on: 
Thursday, March 17, 2022
Cellulose, CAGR, Fermentation, Transport, Growth, Perfume, Environment, Diluent, Carbon, Gasoline, Textile, Biomass, Sugar, Ecosystem, Tax, Lists of countries and territories, Biofuel, Enzyme, Renewable energy

Led by the U.S., North America is a key region in the bio-alcohol market.

Key Points: 
  • Led by the U.S., North America is a key region in the bio-alcohol market.
  • Increase in demand for bio-alcohol as a transportation fuel, agro chemical, and chemical intermediate is propelling the bio-alcohol market in Germany.
  • Stringent government regulations for carbon emissions and government subsidies to support the use of biofuels supports the growth bio-alcohol market in Germany.
  • Keen players in the bio-alcohol market are entering into newer regions to increase their revenue share of the bio-alcohol market.